Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sen. Hatch on dietary supplements

Executive Summary

Senate approves (94-1) Hatch's (R-Utah) amendment for a one-year moratorium on including dietary supplements in upcoming FDA food health claims rules except those already approved as part of the food labeling/health claims law and regulations addressing the recommended daily allowance of vitamins and minerals. The amendment was added Sept. 18 to the HHS FY 1993 appropriations bill, which passed the Senate 82-13. Hatch may also try to add language on supplements to the FDA user fee bill (see related story, p. 5). He recently introduced a bill (S 2305) to prohibit FDA from regulating supplements solely on the basis of their potency or because labeling or advertising makes claims about potency or health benefits ("The Pink Sheet" June 29, T&G-12).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS021500

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel